BCTX vs. BCT.TO
Compare and contrast key facts about Briacell Therapeutics Corp (BCTX) and BriaCell Therapeutics Corp. (BCT.TO).
Performance
BCTX vs. BCT.TO - Performance Comparison
Loading graphics...
BCTX vs. BCT.TO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
BCTX Briacell Therapeutics Corp | -41.07% | -91.61% | -90.34% | 33.87% | -47.22% | 112.31% |
BCT.TO BriaCell Therapeutics Corp. | -42.08% | -91.55% | -90.44% | 36.52% | -47.32% | 117.77% |
Different Trading Currencies
BCTX is traded in USD, while BCT.TO is traded in CAD. To make them comparable, the BCT.TO values have been converted to USD using the latest available exchange rates.
Fundamentals
BCTX:
$11.74M
BCT.TO:
CA$16.11M
BCTX:
-$18.19
BCT.TO:
-CA$17.78
BCTX:
0.39
BCT.TO:
0.38
BCTX:
$0.00
BCT.TO:
CA$0.00
BCTX:
-$111.34K
BCT.TO:
-CA$110.60K
BCTX:
-$31.34M
BCT.TO:
-CA$39.27M
Returns By Period
The year-to-date returns for both stocks are quite close, with BCTX having a -41.07% return and BCT.TO slightly lower at -42.08%.
BCTX
- 1D
- 1.45%
- 1M
- 9.69%
- YTD
- -41.07%
- 6M
- -61.91%
- 1Y
- -88.52%
- 3Y*
- -84.46%
- 5Y*
- -62.57%
- 10Y*
- —
BCT.TO
- 1D
- 2.06%
- 1M
- 8.31%
- YTD
- -42.08%
- 6M
- -62.20%
- 1Y
- -88.69%
- 3Y*
- -84.46%
- 5Y*
- -62.63%
- 10Y*
- -17.24%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BCTX vs. BCT.TO — Risk / Return Rank
BCTX
BCT.TO
BCTX vs. BCT.TO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Briacell Therapeutics Corp (BCTX) and BriaCell Therapeutics Corp. (BCT.TO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BCTX | BCT.TO | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.65 | -0.65 | 0.00 |
Sortino ratioReturn per unit of downside risk | -0.92 | -0.93 | +0.01 |
Omega ratioGain probability vs. loss probability | 0.86 | 0.85 | 0.00 |
Calmar ratioReturn relative to maximum drawdown | -0.95 | -0.96 | 0.00 |
Martin ratioReturn relative to average drawdown | -1.16 | -1.17 | 0.00 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| BCTX | BCT.TO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.65 | -0.65 | 0.00 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.55 | -0.01 | -0.54 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | -0.00 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.54 | -0.00 | -0.54 |
Correlation
The correlation between BCTX and BCT.TO is 0.90, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
BCTX vs. BCT.TO - Dividend Comparison
Neither BCTX nor BCT.TO has paid dividends to shareholders.
Drawdowns
BCTX vs. BCT.TO - Drawdown Comparison
The maximum BCTX drawdown since its inception was -99.79%, roughly equal to the maximum BCT.TO drawdown of -99.87%. Use the drawdown chart below to compare losses from any high point for BCTX and BCT.TO.
Loading graphics...
Drawdown Indicators
| BCTX | BCT.TO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.79% | -99.87% | +0.08% |
Max Drawdown (1Y)Largest decline over 1 year | -93.91% | -94.06% | +0.15% |
Max Drawdown (5Y)Largest decline over 5 years | -99.79% | -99.78% | -0.01% |
Max Drawdown (10Y)Largest decline over 10 years | — | -99.87% | — |
Current DrawdownCurrent decline from peak | -99.77% | -99.85% | +0.08% |
Average DrawdownAverage peak-to-trough decline | -61.03% | -68.73% | +7.70% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 76.84% | 76.91% | -0.07% |
Volatility
BCTX vs. BCT.TO - Volatility Comparison
The current volatility for Briacell Therapeutics Corp (BCTX) is 22.56%, while BriaCell Therapeutics Corp. (BCT.TO) has a volatility of 24.09%. This indicates that BCTX experiences smaller price fluctuations and is considered to be less risky than BCT.TO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| BCTX | BCT.TO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 22.56% | 24.09% | -1.53% |
Volatility (6M)Calculated over the trailing 6-month period | 112.58% | 112.31% | +0.27% |
Volatility (1Y)Calculated over the trailing 1-year period | 137.60% | 137.99% | -0.39% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 114.53% | 9,425.01% | -9,310.48% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 114.19% | 16,294.32% | -16,180.13% |
Financials
BCTX vs. BCT.TO - Financials Comparison
This section allows you to compare key financial metrics between Briacell Therapeutics Corp and BriaCell Therapeutics Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities